MitoKit-CII MitoPedia: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
|mitopedia topic=Medium | |mitopedia topic=Medium | ||
}} | }} | ||
__TOC__ | |||
Line 21: | Line 23: | ||
::::* NV118/MitoKit-CII: 100 mM stock solution - more details [[NV118/MitoKit-CII|here]] | ::::* NV118/MitoKit-CII: 100 mM stock solution - more details [[NV118/MitoKit-CII|here]] | ||
::::* NV161/MitoKit-CII: 10 mM stock solution - more details [[NV161/MitoKit-CII|here]] | ::::* NV161/MitoKit-CII: 10 mM stock solution - more details [[NV161/MitoKit-CII|here]] | ||
== SUITbrowser question: Permeable succinate/malonate == | |||
Work in progress |
Revision as of 15:30, 13 May 2019
Description
Cell permeable prodrugs, composed of NV161/MitoKit-CII and NV118/MitoKit-CII, of the Complex II substrate succinate increase ATP-linked mitochondrial respiration in CI-deficient human blood cells, fibroblasts and heart fibres.
Abbreviation: MitoKit-CII
Reference: MitoKit-CII, Ehinger 2016 Nat Commun
MitoPedia topics:
Media for respirometry
Application in HRR
Preparation
- Both compounds are dissolved in DMSO and stored in aliquots at -20 °C.
- We recommend the following dilutions for reaching the desired concentration in the experiments:
SUITbrowser question: Permeable succinate/malonate
Work in progress